Latest Articles

Publication Date
Endometriosis development in relation to hypoxia: a murine model study.

Endometriosis, due to its ambiguous symptoms, still remains one of the most difficult female diseases to treat, with an average diagnosis time of 7-9 years. The changing level of hypoxia …

Published: Oct. 30, 2024, midnight
Synergistic Inhibitory Effects of Tetramethylpyrazine and Evodiamine on Endometriosis Development.

Endometriosis (EMS) belongs to a gynecological disorder with inflammation and the existence of endometrial-like tissues beyond the uterus, often leading to infertility and pelvic pain. Estrogen receptor β (ERβ) is …

Published: Oct. 30, 2024, midnight
The causal role of gastroesophageal reflux disease in endometriosis: a bidirectional Mendelian randomization study.

Observational studies have reported an association between gastroesophageal reflux disease (GERD) and endometriosis. We conducted a two-sample and bidirectional Mendelian randomization analysis to determine whether those associations are causal. Two-sample …

Published: Oct. 30, 2024, midnight
Non-Hormonal Therapy for Endometriosis Based on Angiogenesis, Oxidative Stress and Inflammation.

Endometriosis is a common gynecological disease that occurs in between 6 and 10% of women who are at reproductive maturity. The presence of endometrial tissue outside the uterine cavity is …

Published: Oct. 30, 2024, midnight
Combination therapy of Sanjie Zhentong capsules for endometriosis: Impact on hormone regulation and serum expression of FOLR1 and MSLN.

Examining the impact of Sanjie Zhentong capsules on hormone levels and serum expression of folate receptor 1 (FOLR1) and Mesothelin (MSLN) in endometriosis patients. A cohort of 150 endometriosis patients …

Published: Oct. 29, 2024, midnight
Periodic Bleeding from a Cesarean Section Scar Fistula.

We present the case of a 36-year-old woman who presented to our clinic for a second opinion. After multiple previous surgeries, she presented with an abdominal wound infection, which was …

Published: Oct. 29, 2024, midnight
Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis - Proactive financial news

Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis Proactive financial news

Published: Oct. 28, 2024, 1:52 p.m.
Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis - Proactive Investors USA

Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis Proactive Investors USA

Published: Oct. 28, 2024, 1:52 p.m.
Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis - Proactive Investors Australia

Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis Proactive Investors Australia

Published: Oct. 28, 2024, 1:52 p.m.
Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of Endometriosis - StockTitan

Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of Endometriosis StockTitan

Published: Oct. 28, 2024, 12:30 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!